Kennedy Capital Management LLC Sells 28,564 Shares of Augmedix, Inc. (NASDAQ:AUGX)

Kennedy Capital Management LLC cut its holdings in Augmedix, Inc. (NASDAQ:AUGX) by 7.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 370,806 shares of the company’s stock after selling 28,564 shares during the period. Kennedy Capital Management LLC owned 0.76% of Augmedix worth $1,517,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Hood River Capital Management LLC raised its stake in shares of Augmedix by 79.0% during the 1st quarter. Hood River Capital Management LLC now owns 490,238 shares of the company’s stock valued at $2,005,000 after purchasing an additional 216,339 shares during the period. PEAK6 Investments LLC purchased a new stake in shares of Augmedix in the first quarter worth about $112,000. Vanguard Group Inc. grew its stake in Augmedix by 16.0% during the first quarter. Vanguard Group Inc. now owns 1,302,424 shares of the company’s stock valued at $5,327,000 after acquiring an additional 179,534 shares in the last quarter. Blair William & Co. IL increased its holdings in Augmedix by 30.6% during the 1st quarter. Blair William & Co. IL now owns 197,454 shares of the company’s stock worth $808,000 after acquiring an additional 46,265 shares during the period. Finally, Oppenheimer Asset Management Inc. purchased a new stake in Augmedix in the 1st quarter worth approximately $56,000. 87.11% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on AUGX shares. B. Riley cut shares of Augmedix from a “strong-buy” rating to a “hold” rating and decreased their price target for the stock from $3.00 to $2.35 in a report on Friday, July 19th. Evercore ISI cut shares of Augmedix from an “outperform” rating to an “inline” rating and decreased their price objective for the stock from $5.00 to $1.50 in a research report on Tuesday, May 14th. Lake Street Capital reissued a “hold” rating on shares of Augmedix in a research note on Monday, July 22nd. Maxim Group cut shares of Augmedix from a “buy” rating to a “hold” rating and set a $5.00 price objective on the stock. in a research report on Tuesday, May 14th. Finally, William Blair lowered shares of Augmedix from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 19th. Four investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $3.09.

Augmedix Stock Performance

Shares of NASDAQ:AUGX opened at $2.27 on Thursday. The company’s fifty day moving average is $1.15 and its 200 day moving average is $2.82. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.73. Augmedix, Inc. has a 52 week low of $0.73 and a 52 week high of $6.25.

Augmedix (NASDAQ:AUGX) last released its quarterly earnings data on Monday, May 13th. The company reported ($0.12) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.12). The firm had revenue of $13.47 million during the quarter, compared to analyst estimates of $13.25 million. Augmedix had a negative return on equity of 178.34% and a negative net margin of 41.95%. As a group, equities research analysts predict that Augmedix, Inc. will post -0.45 EPS for the current fiscal year.

About Augmedix

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.